BackAIM ImmunoTech Overview

AIM ImmunoTech Long Term Debt

Track AIM ImmunoTech's long-term debt ($110K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$105000.00
68.93% YoYΔ $-233000.00 vs prior year quarter

Peer average

Loading

AIM ImmunoTech Long Term Debt History

Loading

AIM ImmunoTech vs. peers: Long Term Debt Comparison

Loading

AIM ImmunoTech Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

AIM ImmunoTech (AIM) FAQ

As of the most recent data (March 2026), AIM shows a long-term debt of $110K. That compares with $340K in the prior-year period — down 68.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, AIM's long-term debt is now $110K (was $340K) — a 68.9% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether AIM ImmunoTech is outperforming or lagging.

Tracking AIM's long-term debt over time shows whether AIM ImmunoTech is scaling, shrinking, or reshaping that part of the business. The current reading is $110K That compares with $340K in the prior-year period — down 68.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this long-term debt page, Stockcircle has AIM ImmunoTech's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term debt (currently $110K) with ownership activity and broader fundamentals.

AIM ImmunoTech's long-term debt is $110K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.